Skip to main content

Advertisement

Table 4 Significant predictors of mortality following type 1 and type 2 myocardial infarction among persons with HIV: Bayesian Model Averaging

From: Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS)

VariableProbability of inclusion in the final model (%)HR*95% CI*P valueProbability of inclusion in the final model (%)HR*95% CI*P value
 Type 1 MI    
Statin use3.3   4.5   
ART use8.8   11.5   
Female2.90.910.53, 1.550.7236.71.240.88, 1.750.219
Diabetes13.9   3.4   
Treated hypertension2.0   19.9   
Age (per 10)100.01.731.37, 2.17< 0.0012.50.970.84, 1.120.664
Black10.8   1.8   
Hispanic3.2   6.3   
Smoker7.6   1.8   
Log10(VL + 1)95.11.251.09, 1.430.00121.0   
CD4 (per 100)4.5   4.3   
VL > 40024.4   33.61.381.00, 1.910.047
eGFR < 30100.03.021.77, 5.14< 0.00111.1   
BMI < 18.59.1   37.91.621.02, 2.560.040
BMI 25 to < 301.9   96.70.550.35, 0.860.009
BMI 30+20.0   1.81.050.68, 1.640.819
  1. *Hazard ratio and confidence interval from Cox model included for potential significant predictors plus age and sex